I-C50H58n7o9p Adenosine, N-Benzoyl-5 -O- [i-bis (4-bis (1-Methyythyl) phosphoramidite

I-Canonical iyancuma

I-N # CCOP (OC1C (OC C = c7) n (c (c) c) c (c) c

I-Ismomeric iyancuma

C (oc [c @@ h] 1 [c @@ h] (OP (o) (C) (C) (C) (C)) (C5) (C5) (C5) (C5) (C5) (C5) (C5) (C5) (C5) (C5) (C5) (C5 = Cc = c (OC) c = c5) (C6 = cc = c (c6) c = c7) c7 = cc = c7

Intshi

I-Inchi = 1s / c50h58n7OP / C1- 34 9-21-25-411 (61-7) 26-229) 65-49 (45-30) (58-16) (58-16) (58-36 / H8-16-26 ,.15-26, 32-35,42,44-45.49h, 14,23-31- 34h2, (H, 49-, 49-, 47-, 67. / M1 / ​​S1 / s1 Simahla Akukho mlinganiselo

Isitshixo se-Inchi

I-VPBYBQBHYHRLHGG

Amanye amagama kule nto

I-adenosine,N-Benzoyl-5 '-O- [BIs (4-I-EAPXXYLL) phenylmethyl] -2 -O- (2-I-AccchsxyEthyl) -, 3 '- [2-cyanothyl Bis (1-Methythyl)

Iphosphoramidite] (9I); I-16: PN: I-US2002112116 iphepha: 19 I-19 16: PN: I-US20021021017 Iphepha: I-20 yeBango lokulandelelana; I-17: PN: I-US200400055569 iphepha: 22 ibango lokulandelelana; I-19: PN: i-US200000603030: 23 I-35 I-19: PN: I-US20044044047

IPHEPHA: 21 Bamba ulandelelwano-ngxelo; I-19: PN: i-US20040014044040 Iphepha: 21 ibango lokulandelelana; I-20: PN: i-US20040005570 iphepha: 20 ibango

ukulandelelana; 20: PN: I-US20040014044040: 21 ibango lokulandelelana; 20: PN: I-US200440140505054050 21: PN: U

S20040005565 iphepha: 17- I-22- I-22 ibango lokulandelelana; 21: PN: I-US2004001405 kwiphepha: 23 I-35 ibango; I-22: PN: i-US20040014694694 23: PN: I-US2000006029 Iphepha: 23 Bamba ulandelelwano-mva; 23: Pn: Wo03106645 Iphepha: 73 ibango lokulandelelana; I-94: P N: I-US20040005707 iphepha: